Several pathways seem to be involved: the Wnt signaling pathway in colorectal cancer or breast cancer; the TGF-β signaling pathway, in gastric or endometrial cancer; and the EGFR/human epidermal growth factor receptor (Her) signaling pathway in epithelial tumors. This evidence concerns the gene TGFB1 and breast carcinoma.